Immune to Cancer: The CRI Blog
-
T.J. Sharpe’s Immunotherapy Story
Melanoma | Diagnosed 2012 When I was in the hospital, I made a vow that when I was… -
Karen Koehler’s Immunotherapy Story
Leukemia | Diagnosed 2011 It was brutal, but I was prepared…I bounced back very quickly. Karen’s Story When… -
Jon Deisher’s Immunotherapy Story
Esophageal Cancer | Diagnosed 2013 Jon’s Story Jon Deisher is a life-long Alaskan who has devoted himself to… -
Ann Silberman’s Immunotherapy Story
Breast Cancer | Diagnosed 2009 You learn to see life in a different way when you know… -
Colorectal Cancer Awareness Month: How Immunotherapy Offers Hope for the Future
March is Colorectal Cancer Awareness Month, and the need for a spotlight on this disease is as…
-
Meet Tecla: 50-Mile Rider in the 2017 Answer to Cancer
For Tecla Palli-Sandler, participating in the 2017 Answer to Cancer Cycling Event and 5K Family…
-
New Biomarker ‘Bim’ Could Enable Smarter Treatment for Melanoma Patients
Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who…
-
Third Immunotherapy Option Approved for Bladder Cancer Patients
On February 2, nivolumab (Opdivo®, Bristol-Myers Squibb) became the newest FDA-approved immunotherapy available for patients with bladder…
-
Immunotherapy Shows Promise Against Previously Untreatable Stomach Cancer
Nivolumab improves survival in patients with advanced stomach cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.